Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial

For almost three decades in many countries azathioprine has been used to treat relapsing-remitting multiple sclerosis. However its efficacy was usually considered marginal and following approval of β interferons for this indication it was no longer recommended as first line treatment, even if presen...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS One
Hoofdauteurs: Massacesi, Luca, Tramacere, Irene, Amoroso, Salvatore, Battaglia, Mario A., Benedetti, Maria Donata, Filippini, Graziella, La Mantia, Loredana, Repice, Anna, Solari, Alessandra, Tedeschi, Gioacchino, Milanese, Clara
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2014
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4234663/
https://ncbi.nlm.nih.gov/pubmed/25402490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113371
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items